Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.

Pathology - 1 Feb 2017

Ross Jeffrey S, Gay Laurie M

Abstract excerpt

Targeting specific mutations that have arisen within a tumour is a promising means of increasing the efficacy of treatments, and breast cancer is no exception to this new paradigm of personalised medicine. Traditional DNA sequencing methods used to characterise clinical cancer specimens and impact treatment decisions are highly sensitive, but are often limited in their scope to known mutational hot spots....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to MTOR gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Mutation

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 28034454
DOI: 10.1016/j.pathol.2016.11.005

Genes

ERBB2
MTOR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.PMID 28034454Read ↗

Next-generation sequencing in breast cancer: current clinical applications and future directionsSemantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer CareSemantic proximity Read ↗

The Cancer Genome Atlas: clinical applications for breast cancer.Semantic proximity Read ↗

Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug Resistance.Semantic proximity Read ↗

Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.Semantic proximity Read ↗

Insight into the heterogeneity of breast cancer through next-generation sequencing.Semantic proximity Read ↗

Whole genome sequencing of breast cancerSemantic proximity Read ↗

Clinical implications of breast cancer tumor genomic testing.Semantic proximity Read ↗

Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology ClinicsSemantic proximity Read ↗

Next-generation sequencing.Semantic proximity Read ↗

The genomic landscape of breast cancer as a therapeutic roadmap.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.